<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE137425" accession="SRP221598">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP221598</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA565417</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE137425</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>mRNA expression changes in CCM3-deficient endothelial cells</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>Loss-of-function variants in CCM3/PDCD10 predispose to cerebral cavernous malformations (CCMs) that are vascular lesion of the central nervous system. Using CRISPR/Cas9 genome editing and RNA sequencing, we have shown that long-term inactivation of CCM3 in human endothelial cells dysregulates fibronectin expression and thus impairs the assembly of a functional fibronectin matrix by endothelial cells. Overall design: Examination of the mRNA expression profile of 3 wild-type CI-huVEC lines and 3 clonal CCM3-knockout CI-huVEC lines.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE137425</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_ATTRIBUTES>
      <STUDY_ATTRIBUTE>
        <TAG>parent_bioproject</TAG>
        <VALUE>PRJNA575850</VALUE>
      </STUDY_ATTRIBUTE>
    </STUDY_ATTRIBUTES>
  </STUDY>
</STUDY_SET>
